Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cellebrite DI (CLBT) Shares Outstanding (Weighted Average) (2020 - 2025)

Historic Shares Outstanding (Weighted Average) for Cellebrite DI (CLBT) over the last 6 years, with Q3 2025 value amounting to $240.0.

  • Cellebrite DI's Shares Outstanding (Weighted Average) fell 8400.0% to $240.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $240.0, marking a year-over-year decrease of 8400.0%. This contributed to the annual value of $209.5 million for FY2024, which is 1015.87% up from last year.
  • Cellebrite DI's Shares Outstanding (Weighted Average) amounted to $240.0 in Q3 2025, which was down 8400.0% from $150.0 recorded in Q2 2025.
  • Cellebrite DI's 5-year Shares Outstanding (Weighted Average) high stood at $209.5 million for Q4 2024, and its period low was $30.0 during Q2 2021.
  • Its 5-year average for Shares Outstanding (Weighted Average) is $38.8 million, with a median of $370.0 in 2023.
  • Its Shares Outstanding (Weighted Average) has fluctuated over the past 5 years, first crashed by 9500.0% in 2023, then surged by 490000.0% in 2024.
  • Over the past 5 years, Cellebrite DI's Shares Outstanding (Weighted Average) (Quarter) stood at $30.0 in 2021, then soared by 608977816.67% to $182.7 million in 2022, then grew by 4.08% to $190.2 million in 2023, then increased by 10.16% to $209.5 million in 2024, then plummeted by 100.0% to $240.0 in 2025.
  • Its last three reported values are $240.0 in Q3 2025, $150.0 for Q2 2025, and $70.0 during Q1 2025.